{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:49:37Z","timestamp":1792838977909,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014349","name":"Society For Maternal-Fetal Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ajog.2023.12.023","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T21:22:13Z","timestamp":1703193733000},"page":"B2-B11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Society for Maternal-Fetal Medicine Consult Series #69: Hepatitis B in pregnancy: updated guidelines"],"prefix":"10.1016","volume":"230","author":[{"given":"Martina L.","family":"Badell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malavika","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.N.","family":"Tita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.12.023_bib1","author":"Hepatitis"},{"key":"10.1016\/j.ajog.2023.12.023_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2023.12.023_bib3","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/hep.31991","article-title":"Prevalence of HBV infection, vaccine-induced immunity, and susceptibility among at-risk populations: US households, 2013-2018","volume":"74","author":"Roberts","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2023.12.023_bib5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/M13-2529","article-title":"Prevention of vertical transmission of hepatitis B: an observational study","volume":"160","author":"Kubo","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2023.12.023_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/INF.0b013e31820cd65c","article-title":"Estimating the number of births to hepatitis B virus-infected women in 22 states, 2006","volume":"30","author":"Din","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajog.2023.12.023_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1542\/peds.2011-2866","article-title":"The national perinatal hepatitis B prevention program, 1994-2008","volume":"129","author":"Smith","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2023.12.023_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/jvh.13060","article-title":"Awareness of chronic viral hepatitis in the United States: an update from the National Health and Nutrition Examination Survey","volume":"26","author":"Kim","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ajog.2023.12.023_bib10","author":"Conners"},{"key":"10.1016\/j.ajog.2023.12.023_bib11","series-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","first-page":"4320","author":"Petersen","year":"2009"},{"key":"10.1016\/j.ajog.2023.12.023_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/AOG.0000000000004652","article-title":"Universal hepatitis B antibody screening and vaccination in pregnancy: a cost-effectiveness analysis","volume":"139","author":"Prabhu","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.023_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0000000000005300","article-title":"Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.023_bib15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-150-12-200906160-00012","article-title":"Screening for hepatitis B virus infection in pregnant women: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement","volume":"150","author":"Lin","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2023.12.023_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jama.2019.9365","article-title":"Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement","volume":"322","author":"United States Preventive Services Task Force","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.12.023_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/bmj.38719.435833.7C","article-title":"Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis","volume":"332","author":"Lee","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.12.023_bib18","author":"Henderson"},{"key":"10.1016\/j.ajog.2023.12.023_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2023.12.023_bib20","doi-asserted-by":"crossref","first-page":"ofx225","DOI":"10.1093\/ofid\/ofx225","article-title":"Comparative effectiveness of prophylactic strategies for perinatal transmission of hepatitis B virus: a network meta-analysis of randomized controlled trials","volume":"4","author":"Chen","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajog.2023.12.023_bib22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine","volume":"2","author":"Beasley","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.12.023_bib23","first-page":"CD008545","article-title":"Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus","volume":"2","author":"Eke","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.12.023_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jogc.2016.11.001","article-title":"No. 342-hepatitis B and pregnancy","volume":"39","author":"Castillo","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2023.12.023_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1743-422X-5-100","article-title":"Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus\u2014a systematic review","volume":"5","author":"Yang","year":"2008","journal-title":"Virol J"},{"key":"10.1016\/j.ajog.2023.12.023_bib26","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1080\/14767058.2020.1819229","article-title":"Cesarean section in reducing mother-to-child HBV transmission: a meta-analysis","volume":"35","author":"He","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.12.023_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s10620-013-2918-0","article-title":"Measures to reduce mother-to-child transmission of hepatitis B virus in China: a meta-analysis","volume":"59","author":"Xu","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajog.2023.12.023_bib28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.midw.2019.03.024","article-title":"Vaginal delivery and HBV mother to child transmission risk after immunoprophylaxis: a systematic review and a meta-analysis","volume":"74","author":"Chen","year":"2019","journal-title":"Midwifery"},{"key":"10.1016\/j.ajog.2023.12.023_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/peds.2004-2491","article-title":"Breastfeeding and the use of human milk","volume":"115","author":"Gartner","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2023.12.023_bib30","first-page":"1049","article-title":"Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers","volume":"99","author":"Hill","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.023_bib31","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/adc.60.10.972","article-title":"Should hepatitis B surface antigen positive mothers breast feed?","volume":"60","author":"de Martino","year":"1985","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ajog.2023.12.023_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02390671","article-title":"Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection","volume":"255","author":"Ko","year":"1994","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2023.12.023_bib33","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3748\/wjg.v17.i31.3640","article-title":"A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population","volume":"17","author":"Chen","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajog.2023.12.023_bib34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00431-006-0327-5","article-title":"Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus","volume":"166","author":"Song","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ajog.2023.12.023_bib35","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1701-2163(15)30546-6","article-title":"RETIRED: prenatal Invasive Procedures in Women with hepatitis B, hepatitis C, and\/or human immunodeficiency virus Infections","volume":"36","author":"Gagnon","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2023.12.023_bib36","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1067\/mob.2001.114866","article-title":"The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood","volume":"184","author":"Towers","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.023_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2013.11.008","article-title":"Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers","volume":"60","author":"Yi","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajog.2023.12.023_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ajog.2013.12.036","article-title":"Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women","volume":"210","author":"Moro","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.023_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B Virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.12.023_bib40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cgh.2007.06.015","article-title":"Risk and predictors of mortality associated with chronic hepatitis B infection","volume":"5","author":"Iloeje","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajog.2023.12.023_bib41","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2023.12.023_bib42","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2023.12.023_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0166-0934(96)02093-9","article-title":"Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA","volume":"62","author":"Hwang","year":"1996","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ajog.2023.12.023_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.26686","article-title":"No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B","volume":"59","author":"Kitrinos","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2023.12.023_bib45","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.cgh.2014.05.024","article-title":"No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B","volume":"12","author":"Corsa","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajog.2023.12.023_bib46","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.cgh.2021.12.012","article-title":"Tenofovir alafenamide for pregnant Chinese women with active chronic hepatitis B: a multicenter prospective study","volume":"20","author":"Zeng","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajog.2023.12.023_bib47","doi-asserted-by":"crossref","first-page":"e3324","DOI":"10.1093\/cid\/ciaa1939","article-title":"Tenofovir alafenamide to prevent perinatal hepatitis B transmission: a multicenter, prospective, observational study","volume":"73","author":"Zeng","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2023.12.023_bib48","article-title":"Safety and efficacy of tenofovir alafenamide fumarate in early-middle pregnancy for Mothers With chronic hepatitis B","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajog.2023.12.023_bib49","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1080\/14767058.2022.2134771","article-title":"Tenofovir alafenamide in blocking mother-to-child transmission of hepatitis B virus: a multi-center, prospective study","volume":"35","author":"Han","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.12.023_bib50","first-page":"6","article-title":"Pregnancy outcomes in pregnant women with HIV on tenofovir disoproxil fumarate (TDF) compared to tenofovir alafenamide (TAF)","volume":"4","author":"Thimm","year":"2022","journal-title":"J AIDS HIV Treat"},{"key":"10.1016\/j.ajog.2023.12.023_bib52","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/infdis\/170.6.1418","article-title":"Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load","volume":"170","author":"Burk","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajog.2023.12.023_bib53","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0264-410X(97)00080-7","article-title":"Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity","volume":"15","author":"del Canho","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.ajog.2023.12.023_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","article-title":"Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study","volume":"16","author":"Xu","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ajog.2023.12.023_bib55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","article-title":"Perinatal transmission of hepatitis B virus: an Australian experience","volume":"190","author":"Wiseman","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.ajog.2023.12.023_bib56","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2011.10.041","article-title":"An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus","volume":"10","author":"Pan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajog.2023.12.023_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","article-title":"Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis","volume":"21","author":"Funk","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajog.2023.12.023_bib58","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/AOG.0000000000000124","article-title":"Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load","volume":"123","author":"Fan","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.023_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cld.2019.04.007","article-title":"Hepatitis B in pregnant women and their infants","volume":"23","author":"Cryer","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ajog.2023.12.023_bib60","article-title":"Clinical characteristics of hepatitis flares during pregnancy and postpartum in Chinese chronic hepatitis B virus carriers-a prospective cohort study of 417 cases","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2023.12.023_bib61","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MCG.0000000000000908","article-title":"Management of chronic hepatitis B in pregnancy","volume":"51","author":"Li","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ajog.2023.12.023_bib62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hep.1840030201","article-title":"Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial","volume":"3","author":"Beasley","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2023.12.023_bib63","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jama.1996.03540110060032","article-title":"Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan","volume":"276","author":"Chen","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.12.023_bib64","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2023.12.023_bib65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal hepatitis B vaccination in adults aged 19-59 years: updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2023.12.023_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations -United states, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.ajog.2023.12.023_bib67","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vaccine.2017.11.039","article-title":"Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016","volume":"36","author":"Moro","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ajog.2023.12.023_bib68","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1016\/j.vaccine.2018.08.074","article-title":"Uptake and safety of hepatitis B vaccination during pregnancy: a Vaccine Safety Datalink study","volume":"36","author":"Groom","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ajog.2023.12.023_bib69","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.32474","article-title":"Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose","volume":"76","author":"Bruce","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2023.12.023_bib70","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/AOG.0b013e3182148efe","article-title":"Efficacy of an accelerated hepatitis B vaccination program during pregnancy","volume":"117","author":"Sheffield","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.023_bib71","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/ciu103","article-title":"Hepatitis B testing and vaccination among adults with sexually transmitted infections in a large managed care organization","volume":"58","author":"Hechter","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2023.12.023_bib72","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/656776","article-title":"Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial","volume":"202","author":"Hwang","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajog.2023.12.023_bib73","doi-asserted-by":"crossref","first-page":"B24","DOI":"10.1016\/j.ajog.2020.12.1200","article-title":"Society for Maternal-Fetal Medicine Special Statement: grading of Recommendations Assessment, Development, and Evaluation (GRADE) update","volume":"224","author":"Norton","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.12.023_bib74","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1016\/j.ajog.2026.04.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000}},{"DOI":"10.1016\/j.ajog.2026.04.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823021737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823021737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:38:44Z","timestamp":1777336724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823021737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0002937823021737"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.12.023","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society for Maternal-Fetal Medicine Consult Series #69: Hepatitis B in pregnancy: updated guidelines","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}